Dengue fever

FDA grants priority review for Sanofi's dengue vaccine candidate

Retrieved on: 
火曜日, 10月 30, 2018
Dengue fever, Tropical diseases, Forward-looking statement

Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans" and similar expressions.

Key Points: 
  • Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans" and similar expressions.
  • Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.
  • Virus-specific differences in Rates of Disease during the 2010 Dengue Epidemic in Puerto Rico.
  • April 4, 2013. http://dx.doi.org/10.1371/journal.pntd.0002159
    3 Shepard, D.S., et al., The global economic burden of dengue: a systematic analysis.

Oxitec to Apply New Generation of Self-limiting Mosquito Technology to Malaria-spreading Mosquitoes

Retrieved on: 
火曜日, 6月 19, 2018
Hexapoda, Ecdysozoa, Medicine, Chikungunya, Malaria, Aedes aegypti, Dengue fever, Yellow fever, RTT, Mosquito, Oxitec, Anopheles

This collaboration will fund the development of a new self-limiting Friendly Anopheles mosquito strain designed to suppress wild malaria vector populations.

Key Points: 
  • This collaboration will fund the development of a new self-limiting Friendly Anopheles mosquito strain designed to suppress wild malaria vector populations.
  • "We've built a strong, proven biological engineering platform capable of developing self-limiting mosquito strains that can be used to combat specific disease-spreading species.
  • Oxitec will be using its new 2nd generation Friendly Mosquito technology to develop an Anopheles albimanus strain to address one of the most important vectors of malaria in the Americas.
  • Oxitec has developed a proven track record with its first self-limiting Friendly Mosquito, OX513A, which was designed to control Aedes aegypti mosquitoes.

Mosquito Squad Expands Services To Southeast Asia

Retrieved on: 
月曜日, 5月 21, 2018
RTT, Medicine, Dengue fever, Zika virus, Hexapoda, Microbiology, Haematophagy, Mosquito, Zika fever, Malaria

RICHMOND, Va., May 21, 2018 /PRNewswire/ --Mosquito Squad, the largest and most trusted mosquito and tick control franchise in North America, announced today it has signed a master license agreement for Indonesia.

Key Points: 
  • RICHMOND, Va., May 21, 2018 /PRNewswire/ --Mosquito Squad, the largest and most trusted mosquito and tick control franchise in North America, announced today it has signed a master license agreement for Indonesia.
  • "Following the launch of our first international markets in East Africa earlier this year, we're continuing to drive our global expansion efforts and are thrilled to be bringing Mosquito Squad services to Southeast Asia," said Chris Grandpre, chairman and chief executive officer of Outdoor Living Brands, parent company of Mosquito Squad.
  • "With dengue fever, malaria and zika remaining concerns in Indonesia, there's a serious need for the lifestyle and disease prevention services Mosquito Squad provides.
  • For additional information on the services available through Mosquito Squad of Indonesia, please email [email protected] .